CAMBRIDGE, Mass., — Insilico Medicine ("Insilico", HKEX: 03696), a clinical-stage biotechnology company powered by generative artificial intelligence (AI), today announced that the company has been ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果